TNF and cancer: Furthermore, LOC inhibition in cancer cells (by LOC-targeting siRNA) attenuated microglia-derived TNF-α expression and this could be overcome by the ectopic supplementation of rhMIF1 (Extended Data Fig. 3c), suggesting that cancer cell-derived MIF1 recruits GAMs, which in turn could positively activate cancer cells via TNF-α.